Lanfranco Pellesi is an expert in Neurology at University of Southern Denmark (Denmark). As of October 2026, ScienceLeadR ranks Lanfranco Pellesi in the top 1% of experts worldwide for Headache, Headache Disorders and Pain. Lanfranco Pellesi has authored 86 publications, the most recent in 2026, and is an investigator in 9 clinical trials, 2 of them ongoing. SLR score: 427 (community average: 125). How the SLR is computed.

LeadR Profile

Lanfranco Pellesi University of Southern Denmark Denmark
427 ScienceLeadR Reputation 427
Network Map

Neurology

Subspecialties: Pharmacy - Biochemistry - Immunology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2016 - 2026

Source: PubMed

University of Southern Denmark

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 86

Citations

Citations: 1 152 1st author: 35 Last author: 13 Unique author: 5


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Same trials, different answers: reconciling four meta-analyses of anti-CGRP antibodies in cluster headache.
PMID 42855968 — headache, antibodies, pain management, cluster headache
Pain Manag20260
Migraine and Obesity: From Shared Mechanisms to Therapeutic Strategies.
PMID 42853529 — glucagon-like peptide 1, weight gain, migraine disorders, obesity, therapeutics
Neurol Ther20260
Fasting-induced headache in Ramadan: a scoping review with implications for clinical practice.
PMID 42841395 — headache, fasting, dehydration, eating, pain, homeostasis, pain management, migraine disorders, diet, substance withdrawal syndrome
Pain Manag20260
Airplane headache: a scoping review of mechanisms and reported therapeutic strategies.
PMID 42779178 — headache, pain, pain management, migraine disorders, atmospheric pressure, therapeutics, headache disorders
Pain Manag20260
Dopaminergic Dysregulation in Migraine: From Hypothalamic A11 Dysfunction to a Systemic Biobehavioral Phenotype.
PMID 42653268 — genes, neuroimaging, hypothalamus, phenotype, migraine disorders, dopamine, restless legs syndrome, attention deficit disorder with hyperactivity
Int J Mol Sci20260

Clinical Studies 9

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 5
Phase 1/Phase 2 4

By status:

Completed 3
Unknown 3
Recruiting 2
Active not recruiting 1

By type:

Interventional 8
Observational 1

By Monocentric/Multicentric:

monocentric 9
multicentric2to4 0
multicentric5to9 0
multicentricup10 0

Main Topics

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
The headache inducing effects of sildenafil in men and women with episodic migraine without aura
2024-512014-17-02 — headache, migraine disorders, migraine without aura, men, women
Phase 1/Phase 2Active not recruiting2024
The headache inducing effects of cilostazol in men and women with migraine without aura
2025-521520-29-00 — headache, cilostazol, migraine disorders, migraine without aura, men, women
Phase 1/Phase 2Recruiting2025

LeadR Networks

Main global connection map